JPRN-UMIN000019397未知3 期
Pharmacogenomic study to predict warfarin stable dose in Japanese chidren. - Pharmacogenomic study to predict warfarin stable dose in Japanese chidren.
ational Center for Child Health and Development0 个研究点目标入组 480 人开始时间: 2015年11月1日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 发起方
- 入组人数
- 480
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 1days-old 至 18years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients whose warfarin dose has been changed within 28 days of the date of DNA sample collection Pregnant women and lactating women Patients who did not give written informed consent Patients who regularly (at least once/week) consume vitamin K-rich foods and supplements such as natto, chlorella, green juice, and St. John's wort (Hypericum perforatum) Patients who are judged by the attending physician to be inappropriate as subjects for this study
研究者
相似试验
Unknown
4 期
Applying Pharmacogenetics to Warfarin Dosing in Chinese PatientsDeep Vein ThrombosisHeart Valve DiseaseAtrial FibrillationPulmonary EmbolismNCT01610141Chinese PLA General Hospital500
已完成
不适用
Genotype-guided Warfarin Individualized TreatmentAtrial FibrillationDeep Venous ThrombosisNCT02211326The Third Xiangya Hospital of Central South University660
已完成
不适用
Pharmacogenetics of Warfarin Induction and InhibitionHealthyNCT01447511University of Minnesota39
已完成
4 期
Comparison of Warfarin Dosing Using Decision Model Versus Pharmacogenetic AlgorithmDeep Vein ThrombosisAtrial FibrillationPulmonary EmbolismNCT00511173Creighton University102
已完成
不适用
Genotype-Based Warfarin Therapy (GENWAT) studyAtrial fibrillationJPRN-UMIN000006794RIKE1,000